Search images on Google Product Monograph
Active Ingredients:
- omalizumab, 150 MG/VIAL
DIN: 02260565
Dosage Form(s): POWDER FOR SOLUTION
Route(s) of Administration: SUBCUTANEOUS
Schedule: Prescription
Company: NOVARTIS PHARMACEUTICALS CANADA INC – official site
ATC:
- R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES (ATC, WHO, Wiki)
- R03D - OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES (ATC, WHO)
- R03DX - Other systemic drugs for obstructive airway diseases (ATC, WHO)
- R03DX05 - OMALIZUMAB (WHO)
Reference brand drug: Xolair
Packaging:
- Package size unit: No information
- Package type: No information
- Package size: No information
- Product information: 1.2ML
External Links for Xolair:
Search on Google
Novartis Pharmaceuticals Canada Inc
Go to Novartis website to see drug product details. Sometimes you can find xolair photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.